Study · Non-randomized trial · n = 7 · 1977
5 resultsBartsch W, Horst HJ, Becker H, Nehse G
Acta endocrinologica1 Jul 1977Cited by 50 (Europe PMC)
The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)
Text rights: Publisher copyright. Results still quote short attributed sentences.
5 results from studies that gave the peptide. 5 results from people.
In patients with oligozoospermia, HCG significantly increased plasma testosterone.
In plain wordsIn patients with low sperm counts, HCG increased blood testosterone.
n = 7
Source sentences
8) Treatment with HCG (Primogonyl) of patients suffering from oligozoospermia resulted in a significant increase of T, DHT and Oe2.
In patients with oligozoospermia, HCG significantly increased plasma dihydrotestosterone.
In plain wordsIn patients with low sperm counts, HCG increased blood dihydrotestosterone.
n = 7
Source sentences
8) Treatment with HCG (Primogonyl) of patients suffering from oligozoospermia resulted in a significant increase of T, DHT and Oe2.
In patients with oligozoospermia, HCG significantly increased plasma oestradiol.
In plain wordsIn patients with low sperm counts, HCG increased blood oestradiol.
n = 7
Source sentences
8) Treatment with HCG (Primogonyl) of patients suffering from oligozoospermia resulted in a significant increase of T, DHT and Oe2.
In patients with oligozoospermia, HCG did not alter SHBG binding capacity.
In plain wordsIn patients with low sperm counts, HCG did not change SHBG binding capacity.
n = 7
Source sentences
8) Treatment with HCG (Primogonyl) of patients suffering from oligozoospermia resulted in a significant increase of T, DHT and Oe2. SHBG was not altered. DHT/T-ratio decreased. n=7.
In patients with oligozoospermia, HCG decreased the DHT/testosterone ratio.
In plain wordsIn patients with low sperm counts, HCG decreased the DHT/testosterone ratio.
n = 7
Source sentences
DHT/T-ratio decreased. n=7.
8) Treatment with HCG (Primogonyl) of patients suffering from oligozoospermia resulted in a significant increase of T, DHT and Oe2.
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.
Version 2Current
14 Oct 2026, 05:02 UTC
Study results updated
Version 1
14 Oct 2026, 01:46 UTC
First added · source update from Europe PMC
Terms as the source lists them.
PepBank is a research reference. Talk to a doctor before you use any peptide.
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated